Hair loss affects millions globally, presenting both physical and emotional challenges. ReGrowth Biotech has developed proprietary Dermal Papilla Growth (D.P.G.) technology—the first comprehensive solution that addresses hair loss at its cellular foundation—regenerating new follicles rather than simply managing symptoms.
Hair's Cellular Potential: Storage and Future Protection
The company's cellular storage technology serves as a biological insurance policy for your hair. The approach involves preserving dermal papilla cells—master controllers of hair follicles—through advanced freezing techniques for future therapeutic use.
From 20 Follicles to Complete Restoration
The treatment process begins with extracting just 20 healthy hair follicles in a 20-minute procedure under local anaesthesia. The extracted follicles are processed in specialised laboratories to isolate and multiply regenerative cells, which are then reinjected into the scalp to stimulate new follicle generation.
International Recognition at June 2025 Cell Surgery Conference
ReGrowth Biotech presented their technology at the 12th International Cell Surgery Conference in June 2025, gaining validation from the global scientific community. The presentation highlighted how their regenerative approach differs from conventional treatments.
The Future of Hair Restoration
The company's cellular approach represents a shift toward preventive, personalised healthcare addressing biological foundations of hair loss rather than temporary symptom management.
This content is provided for educational purposes and general information. Individual treatment outcomes may vary, and all medical decisions should be made in consultation with qualified healthcare professionals.
